Michelle's Moment: New FDA Guidance - LATEX FREE? Blog Feature
Michelle Lott

By: Michelle Lott on January 14th, 2015

Print/Save as PDF

Michelle's Moment: New FDA Guidance - LATEX FREE?

Regulatory Compliance

GL4090-2000-2000

Pulse CheckNew FDA Guidance: "Recommendations for Labeling Medical Products to Inform Users that the Product Container is Not Made with Natural Rubber Latex"

Michelle's Moment: As a result of the FDA's new guidance document on the labeling of products containing natural rubber latex, companies should no longer user the term "latex-free." In this guidance the FDA expressed concern over analytical methods available to support a claim that a material is "free" of latex.

Recently phthalates have become a rising concern of the FDA. Many submissions have received detailed questions regarding the presence or absence of the phthalate DEHP, a known endocrine blocker and common component of flexible PVC. In the European Union phthalates have been on the Substances of Very High Concern list since 2010.

Companies wishing to make claims regarding DEHP should proactively consider using similar statements for claims that a product is "free" of any materials. In addition to a statement on latex content, any manufacturers also include statements about phthalates, such as "DEHP - free." To make such a statement the FDA expects that the manufacturers have analytical data to support that the device contains less than 0.01% of the material. Manufacturers without such data should use statements similar to those recommended for latex, "not made with chemicals containing DEHP."